Hypoenorrhin muscle
Hypoenorrhin muscle's disease overview
What isWhat is hypertrophic cardiomyopathy?
Enthetrative cardiomyopathy is classified as a disease of the heart muscle. It is not physiological hypertrophy or secondary hypertrophy as in people with perennial hypertension. In hypertrophic cardiomyopathy, the left ventricular walls are abnormally thick, especially the ventricular walls, which can impair diastolic function, clogged the left ventricular and have dangerous arrhythmia. P>
Causes of Hypoenorrhin muscle's disease
The cause of hypertrophic cardiomyopathy is due to genetic abnormalities, mostly mutations of myosin heavy chain encoding genes.
Symptoms of Hypoenorrhin muscle's disease
Agent hypertrophic cardiomyopathy may be asymptomatic, accidentally discovered through medical examination or screening in families with sick people. The possible symptoms:
People at risk for Hypoenorrhin muscle's disease
There are parents with hypertrophic cardiomyopathy: If parents are sick, the possibility of children will carry the disease gene is 50%
Prevention of Hypoenorrhin muscle's disease
There is currently no measure to prevent hypertrophic cardiomyopathy, mainly screening to detect early in families with relatives.
Diagnostic measures for Hypoenorrhin muscle's disease
Magnetic resonance: It is also a very useful means to identify hypertrophic myocardial disease, evidence of scars, myocardial fibrosis
Hypoenorrhin muscle's disease treatments
Treatment of hypertrophic cardiomyopathy includes medical treatment, intervention or surgery depending on the degree of disease.
Medical treatment
When the patient has symptoms, the pressure difference is left out of the left ventricle ≥50mmHg, whether the optimal medical treatment has been treated, it is necessary to consider burning alcohol walls or surgery. P>
Suddenly died -prophylactic ICD transplant: It is recommended for patients with durable rapid, ventricular vibration causing fainting or hemodynamic loss, expectation of living over 1 year
See also:
![](https://drugslib.com/public/donate.png)
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions